Source: Oncology reports. Unidade: FM
Subjects: POLIMORFISMO, MARCADOR MOLECULAR, PROGNÓSTICO, NEOPLASIAS DE CABEÇA E PESCOÇO (QUIMIOTERAPIA), CARCINOMA DE CÉLULAS ESCAMOSAS (CIRURGIA), QUIMIOTERAPIA ADJUVANTE, ANTINEOPLÁSICOS (TOXICIDADE)
ABNT
CASTRO, Gilberto de et al. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, v. 25, n. 3, p. 693-699, 2011Tradução . . Disponível em: https://doi.org/10.1200/jco.2010.28.15_suppl.5540. Acesso em: 15 nov. 2024.APA
Castro, G. de, Pasini, F. S., Siqueira, S. A. C., Ferraz, A. R., Villar, R. C., Snitcovsky, I. M. L., & Federico, M. H. H. (2011). ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation. Oncology reports, 25( 3), 693-699. doi:10.1200/jco.2010.28.15_suppl.5540NLM
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540Vancouver
Castro G de, Pasini FS, Siqueira SAC, Ferraz AR, Villar RC, Snitcovsky IML, Federico MHH. ERCC1 protein, mRNA expression and T19007C polymorphism as prognostic markers in head and neck squamous cell carcinoma patients treated with surgery and adjuvant cisplatin-based chemoradiation [Internet]. Oncology reports. 2011 ; 25( 3): 693-699.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1200/jco.2010.28.15_suppl.5540